Erik P Sulman Selected Research

Erik P Sulman Research Topics

Disease

65	Neoplasms (Cancer) 05/2024 - 06/2007
51	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 06/2007
35	Glioma (Gliomas) 01/2022 - 01/2010
20	Brain Neoplasms (Brain Tumor) 12/2023 - 01/2011
6	Meningioma (Meningiomas) 05/2024 - 05/2015
4	Neoplasm Metastasis (Metastasis) 12/2023 - 11/2020
4	Melanoma (Melanoma, Malignant) 10/2022 - 10/2017
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 12/2007
3	Breast Neoplasms (Breast Cancer) 08/2023 - 11/2012
2	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 01/2013
2	Astrocytoma (Pilocytic Astrocytoma) 01/2024 - 03/2019
2	Inflammation (Inflammations) 01/2022 - 07/2015
2	Neutropenia 10/2018 - 02/2014
2	Disease Progression 10/2018 - 02/2014
1	Thyroid Diseases (Thyroid Disease) 05/2024
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 05/2024
1	Alzheimer Disease (Alzheimer's Disease) 12/2023
1	Lymphopenia (Lymphocytopenia) 01/2021

Drug/Important Bio-Agent (IBA)

14	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 02/2014
11	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2013
10	Biomarkers (Surrogate Marker)IBA 05/2024 - 07/2009
7	RNA (Ribonucleic Acid)IBA 01/2023 - 03/2015
6	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2010
6	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2021 - 04/2015
6	MicroRNAs (MicroRNA)IBA 10/2019 - 03/2015
5	MethyltransferasesIBA 11/2021 - 07/2017
4	epidermal growth factor receptor VIIIIBA 01/2023 - 06/2007
4	veliparibIBA 10/2021 - 05/2016
3	Memantine (Namenda)FDA Link 12/2023 - 01/2019
3	ErbB Receptors (EGF Receptor)IBA 01/2023 - 06/2007
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2021 - 10/2018
3	Protons (Proton)IBA 01/2021 - 01/2021
3	Tyrosine (L-Tyrosine)FDA Link 12/2019 - 01/2019
3	Messenger RNA (mRNA)IBA 12/2018 - 01/2013
2	LigandsIBA 05/2024 - 01/2019
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 07/2015
2	Histones (Histone)IBA 01/2021 - 05/2015
2	ChromatinIBA 01/2021 - 01/2018
2	Therapeutic UsesIBA 01/2020 - 01/2019
2	ParaffinIBA 11/2019 - 02/2010
2	Formaldehyde (Formol)FDA Link 11/2019 - 02/2010
2	AntigensIBA 01/2019 - 10/2017
2	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 07/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2018 - 01/2017
2	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 10/2018 - 01/2016
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2018 - 02/2016
2	Molecular Chaperones (Chaperone, Molecular)IBA 10/2017 - 05/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2017 - 10/2015
2	Alkylating AgentsIBA 03/2017 - 02/2010
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2017 - 05/2015
2	Hematoxylin (Haematoxylon)IBA 01/2017 - 05/2015
2	CateninsIBA 02/2016 - 11/2012
2	Valproic Acid (Depakote)FDA LinkGeneric 11/2015 - 11/2012
2	Bevacizumab (Avastin)FDA Link 02/2014 - 01/2014
2	Explosive Agents (Explosives)IBA 02/2011 - 01/2011
1	Radioisotopes (Radionuclides)IBA 05/2024
1	AntibodiesIBA 05/2024
1	boldenone undecylenate (Equipoise)IBA 05/2024
1	Apolipoproteins E (ApoE)IBA 12/2023
1	ApolipoproteinsIBA 12/2023
1	lutetium Lu 177 dotatateIBA 12/2023
1	RadiopharmaceuticalsIBA 12/2023
1	somatostatin receptor 2IBA 12/2023
1	gallium Ga 68 dotatateIBA 12/2023
1	Adenosine Monophosphate (AMP)IBA 01/2023
1	depatuxizumab mafodotinIBA 01/2023
1	VemurafenibIBA 10/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Acyl-CoA Dehydrogenase (Medium-Chain Acyl-Coenzyme A Dehydrogenase)IBA 11/2021
1	Protein Isoforms (Isoforms)IBA 11/2021
1	LipidsIBA 11/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2021
1	CytokinesIBA 10/2021
1	InterferonsIBA 10/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	GuanineIBA 01/2021
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2021
1	Casein Kinase II (Casein Kinase 2)IBA 01/2021
1	Immune Checkpoint ProteinsIBA 10/2020
1	WP1066IBA 01/2020
1	talazoparibIBA 01/2020
1	X-linked Nuclear ProteinIBA 03/2019
1	Mefloquine (Lariam)FDA LinkGeneric 01/2019
1	Beclin-1IBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Sirolimus (Rapamycin)FDA Link 01/2019
1	chloroquine diphosphate FDA LinkGeneric 01/2019
1	rovalpituzumab tesirineIBA 01/2019

Therapy/Procedure

38	Therapeutics 05/2024 - 07/2009
23	Radiotherapy 05/2024 - 12/2007
8	Drug Therapy (Chemotherapy) 01/2023 - 01/2009
5	Immunotherapy 01/2024 - 01/2016
3	Precision Medicine 05/2024 - 01/2014
2	Aftercare (After-Treatment) 01/2024 - 12/2023
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021 - 01/2021
2	Re-Irradiation 01/2017 - 02/2009
1	Cranial Irradiation 07/2022
1	Biological Therapy 01/2021
1	Proton Therapy 01/2021